Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT00067431 · ClinicalTrials.gov registry record · Phase 3

A Study of the Safety and Efficacy of Depakote Sprinkle Capsules in the Treatment of Partial Seizures in Children

A Phase 3 study, sponsored by Abbott.

Terminated
Registry status
Phase 3
Development phase
300
Enrollment target

NCT00067431: Clinical Trial Phase 3 study, sponsored by Abbott.

NCT00067431 is a Phase 3 study that was terminated before completion, run by Abbott. The registered enrollment target is 300 participants, below the 772-participant average among 15,282 other Phase 3 trials with a reported enrollment target (61% lower). According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT00067431, a Phase 3 study, was terminated before completion, sponsored by Abbott.

TERMINATED
Registry status
Phase 3
Development phase
300 participants
Enrollment target

Study Summary

The purpose of this study is to compare the safety and efficacy of two concentration ranges of valproate using Depakote Sprinkle Capsules as adjunctive therapy in the treatment of partial seizures, with or without secondary generalization, in children 3-10 years.

Interventions

  • DRUG Divalproex Sodium (Depakote® Sprinkle Capsules)

Trial Details

FieldValue
Enrollment Target 300 participants
Start Date 2003-07
Phase Phase 3
Abbott

181 total trials

Why NCT00067431 stopped before completion

NCT00067431 is an interventional study that assigns participants to a tested intervention. The registered 300 participants enrollment target is mid-sized for trials with a published cap, below the 772-participant average among 15,282 other Phase 3 trials with a reported enrollment target (61% lower).

The record links to 0 conditions, and to 1 intervention - of which Divalproex Sodium (Depakote® Sprinkle Capsules) is the first listed.

NCT00067431 does not publish any study locations in the registry export this page uses.

Frequently Asked Questions

What is clinical trial NCT00067431 about?

NCT00067431 is a clinical study titled "A Study of the Safety and Efficacy of Depakote Sprinkle Capsules in the Treatment of Partial Seizures in Children". The purpose of this study is to compare the safety and efficacy of two concentration ranges of valproate using Depakote Sprinkle Capsules as adjunctive therapy in the treatment of partial seizures, with or without secondary generalization, in children 3-10 years.

What is the current status of trial NCT00067431?

This trial is currently terminated. It is a Phase 3 study. The enrollment target is 300 participants. The study started on 2003-07.

What interventions are being tested in trial NCT00067431?

The interventions under investigation include: Divalproex Sodium (Depakote® Sprinkle Capsules) (DRUG).

Who is sponsoring clinical trial NCT00067431?

This trial is sponsored by Abbott, which has 181 total clinical trials registered on ClinicalTrials.gov.

How this trial's enrollment target compares

Where NCT00067431's enrollment target sits among peer trials

300 1122nd of 2000 higher than 840 of 2,000 other Phase 3 trials

participants (enrollment target), bucketed by value

Each bar is a band; taller bars hold more other Phase 3 trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.

Source ClinicalTrials.gov registry export · 2026-08-08

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT00353483 · 300 participants

    Effect of Neoadjuvant or Adjuvant Systemic Therapy on Breast Cancers, Bone Marrow Cancer Cells, and Circulating Cancer Cells

  • NCT00588185 · 300 participants · NA

    [18F]-Fluoro-2-Deoxy-D-Glucose and -[18F] Dihydro-Testosterone Pet Imaging in Patients With Progressive Prostate Cancer

  • NCT00682032 · 300 participants · NA

    The Effect of Beta-glucan in Non-Small Cell Lung Cancer

  • NCT00870064 · 300 participants · NA

    The Treatment of Type I Open Fractures in Pediatrics

Similar registry start date

  • NCT05988463 · started 2027-01-01 · Phase 1

    Dose-Escalation Study of Artesunate Patients With IPF

  • NCT07219706 · started 2026-12-10 · NA

    Dietary Fiber and Time Restricted Eating

  • NCT02831335 · started 2026-12-01

    Technical Development of Multi-Parametric Renocerebral MRI

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

Source: ClinicalTrials.gov NCT00067431, the US trial registry maintained by the National Library of Medicine. NCT00067431 (mid enrollment · none site footprint · terminated) retrieved and formatted by PlainTrial, see methodology.